Anna Collén

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Pulmonary Artery

Placebo Controlled

Aortic Dissection

Top Venues

Journal of the American Heart Association

Nature reviews. Drug discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad, Ye Yang, Vijayalakshmi Varma, Christopher Jones, Joanne Goodman, Vincent F S Dubois, Angelica L Quartino, Sotirios K Karathanasis, Liron Abuhatzira, Anna Collén, Charalambos Antoniades, Michael J Koren, Ruchi Gupta, Richard T George
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results. Journal of the American Heart Association 12 (3) (2023)
Elizabeth M Florida, Haiou Li, Christin G Hong, Emily L Ongstad, Ranjitha Gaddipati, Sadichha Sitaula, Vijayalakshmi Varma, Philip M Parel, Ross O'Hagan, Marcus Y Chen, Heather L Teague, Martin P Playford, Sotirios K Karathanasis, Anna Collén, Nehal N Mehta, Alan T Remaley, Alexander V Sorokin
Relationship of Soluble Lectin-Like Low-Density Lipoprotein Receptor-1 (sLOX-1) With Inflammation and Coronary Plaque Progression in Psoriasis. Journal of the American Heart Association (2023)
Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad, Ye Yang, Vijayalakshmi Varma, Christopher Jones, Joanne Goodman, Vincent F S Dubois, Angelica L Quartino, Sotirios K Karathanasis, Liron Abuhatzira, Anna Collén, Charalambos Antoniades, Michael J Koren, Ruchi Gupta, Richard T George
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results. Journal of the American Heart Association 12 (3) (2023)
Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad, Ye Yang, Vijayalakshmi Varma, Christopher Jones, Joanne Goodman, Vincent F S Dubois, Angelica L Quartino, Sotirios K Karathanasis, Liron Abuhatzira, Anna Collén, Charalambos Antoniades, Michael J Koren, Ruchi Gupta, Richard T George
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results. Journal of the American Heart Association (2023)
Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad, Ye Yang, Vijayalakshmi Varma, Christopher Jones, Joanne Goodman, Vincent F S Dubois, Angelica L Quartino, Sotirios K Karathanasis, Liron Abuhatzira, Anna Collén, Charalambos Antoniades, Michael J Koren, Ruchi Gupta, Richard T George
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results. Journal of the American Heart Association 12 (3) (2023)
Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad, Ye Yang, Vijayalakshmi Varma, Christopher Jones, Joanne Goodman, Vincent F S Dubois, Angelica L Quartino, Sotirios K Karathanasis, Liron Abuhatzira, Anna Collén, Charalambos Antoniades, Michael J Koren, Ruchi Gupta, Richard T George
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results. Journal of the American Heart Association 12 (3) (2023)
Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad, Ye Yang, Vijayalakshmi Varma, Christopher Jones, Joanne Goodman, Vincent F S Dubois, Angelica L Quartino, Sotirios K Karathanasis, Liron Abuhatzira, Anna Collén, Charalambos Antoniades, Michael J Koren, Ruchi Gupta, Richard T George
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results. Journal of the American Heart Association 12 (3) (2023)
Anna Collén, Nils Bergenhem, Leif Carlsson, Kenneth R Chien, Stephen Hoge, Li-Ming Gan, Regina Fritsche-Danielson
VEGFA mRNA for regenerative treatment of heart failure. Nature reviews. Drug discovery (2021)